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Abstract
Studies of morbidity compression routinely report the average number of years spent in an unhealthy state but do not report 
variation in age at morbidity onset. Variation was highlighted by Fries (1980) as crucial for identifying disease postpone-
ment. Using incidence of first hospitalization after age 60, as one working example, we estimate variation in morbidity onset 
over a 27-year period in Denmark. Annual estimates of first hospitalization and the population at risk for 1987 to 2014 were 
identified using population-based registers. Sex-specific life tables were constructed, and the average age, the threshold age, 
and the coefficient of variation in age at first hospitalization were calculated. On average, first admissions lasting two or 
more days shifted towards older ages between 1987 and 2014. The average age at hospitalization increased from 67.8 years 
(95% CI 67.7–67.9) to 69.5 years (95% CI 69.4–69.6) in men, and 69.1 (95% CI 69.1–69.2) to 70.5 years (95% CI 70.4–70.6) 
in women. Variation in age at first admission increased slightly as the coefficient of variation increased from 9.1 (95% CI 
9.0–9.1) to 9.9% (95% CI 9.8–10.0) among men, and from 10.3% (95% CI 10.2–10.4) to 10.6% (95% CI 10.5–10.6) among 
women. Our results suggest populations are ageing with better health today than in the past, but experience increasing diver-
sity in healthy ageing. Pensions, social care, and health services will have to adapt to increasingly heterogeneous ageing 
populations, a phenomenon that average measures of morbidity do not capture.
Keywords Morbidity compression · Ageing and health · Age at morbidity onset · Hospital admission
Background
Remaining life expectancy at age 60 has increased across 
developed countries [1]. Whether the extra years of life are 
spent in good or bad health remains unclear, and depends 
on how health is measured [2–7]. Fries proposed a scenario 
where ‘the amount of disability can decrease as morbidity 
is compressed into the shorter span between the increas-
ing age at onset of disability and death’ [8]. Gruenberg was 
more pessimistic, arguing that technological advancement 
would allow people to live for longer but in a prolonged state 
of poor health [9]. Manton suggested that falling mortality 
rates would be associated with a change in the distribution 
of disease types [10]. Specifically, an increase in the num-
ber of years spent with moderate health conditions and a 
decrease in the number of years spent with serious health 
conditions. The typical approach for evaluating which sce-
nario might be emerging as populations are ageing, is to 
compare disability-free life expectancy (DFLE) or healthy 
life expectancy (HLE) with life expectancy [11–14]. If gains 
in DFLE or HLE are smaller than gains in life expectancy, 
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then morbidity expansion is likely. If gains in DFLE or HLE 
are greater than gains in life expectancy, morbidity compres-
sion is likely.
Key to Fries (1980) theory of morbidity compression 
is that the years spent with bad health or disability would 
become increasingly concentrated at the end of life. This 
implies that the age at morbidity onset should become 
increasingly homogenous within populations. This dimen-
sion is well established in mortality compression research, 
which focuses on changes to the variation in age at death 
[15, 16]. However, changes to the variation in age at mor-
bidity onset have largely been overlooked in the morbidity 
compression debate. This has important implications beyond 
theory. For individuals, variation in age at morbidity onset 
represents the amount of uncertainty in the timing of health 
deterioration. At the macro-level, pensions, social care, and 
health services will have to adapt to the heterogeneous needs 
of ageing populations, something that average measures can-
not identify [16].
Reducing rates of morbidity onset at any age increases 
the average age at morbidity onset. Variation in age at onset 
reductions depend on the balance between reducing rates at 
younger ages, which compresses the age-at-morbidity-onset 
distribution into a narrower age span, and reducing rates at 
older ages, which increases variation by pulling out the right 
tail of the age-at-morbidity-onset distribution. For variation 
in the age at morbidity onset to decrease, onset at younger 
ages needs to be reduced faster than onset at older ages [16]. 
This would also ensure that the average age at morbidity 
onset increases.
There is no universal indicator of morbidity. Most esti-
mates of DFLE or HLE use prevalence based estimates of 
disability or functional limitations, typically derived from 
self-reported health surveys [11, 17]. In order to estimate 
variation in the age at morbidity onset, it is necessary to 
have incidence based estimates of morbidity onset [7]. This 
requires longitudinal data, as opposed to cross-sectional 
data, which are rarely available for entire populations. The 
growth in access to administrative healthcare data, which can 
be linked with information on the underlying background 
population, may provide new opportunities for identifying 
indicators of morbidity beyond the concepts of self-reported 
disability or functional limitations [6]. Hospital admissions 
are one potential source of data which are suitable for esti-
mating the incidence rate of medically diagnosed conditions 
for entire populations [18–21], and have been used to exam-
ine temporal changes in population-level health [22–24].
In this paper, we calculate variation in the age at morbid-
ity onset, using hospital admissions data for all individuals 
aged 60 + between 1987 and 2014 in Denmark, as a work-
ing example. The ageing population structure in Denmark 
is comparable to many other developed countries. Unique to 
Denmark is that data exist for constructing individual-level 
hospitalization trajectories for the total population covering 
a substantial period of time [18, 25].
Methods and materials
Data
We linked individual level records, covering the total Dan-
ish population, from the National Patient Register (NPR) 
with data from the Central Population Register (CPR) using 
the unique personal identification number (CPR-Number). 
The NPR contains information on all treatments provided 
in Danish hospitals since 1977 [25]. Reporting of hospital 
admissions is compulsory, leading to high levels of com-
pleteness and reliability. The CPR includes socio-demo-
graphic information on the population alive and residing in 
Denmark since 1968, including sex, place and date of birth, 
and date of death [26].
Study population
As hospitalization data for Denmark began in 1977, we were 
not able to identify admissions before this year. To ensure 
comparability throughout the study period, we created an 
identical cohort study population and consistently applied 
the same method for each calendar year between 1987 (to 
allow for the maximum washout period) and 2014. Figure 1 
summarizes the process of identifying the study population 
in 1987 as an example year.
First, we linked CPR and NPR information on all inpa-
tient admissions and the population alive and residing in 
Denmark aged 60 + . Second, we identified all individuals 
hospitalized within the previous 7-year period—irrespective 
of length of stay, and excluded these individuals from the 
analyses for that particular year. This 7-year washout period 
was used to limit the chance that a first event is a readmission 
or a follow-up treatment [20, 27]. Third, from the remaining 
individuals, we identified the population at risk and the first 
events within each calendar year. We defined first events 
as the first inpatient hospitalization after age 60, from all 
causes, lasting for at least two days. This definition is likely 
to capture hospital admissions that would require inpatient 
care consistently throughout the study period. Events were 
included regardless of whether the outcome was death or 
discharge. Trends over time in the number of individuals at 
risk, first events, and those excluded in the washout period 
are given in Appendix 1 (Supplementary Material).
Statistical analysis
From the number of first hospital admissions and the popula-
tion at risk, we estimated age-specific risks of first admission 
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( qx,thosp ), for each age x and each calendar year t , for men 
and women separately. We constructed period life tables for 
each calendar year using standard demographic methodol-
ogy [28]. Using age-specific risks to have a first event at age 
x in year t  ( qx,thosp ), we estimated ex,thosp , which is con-
ditional upon survival to age 60. The definition of ex,thosp 
is equivalent to the definition of remaining life expectancy 
at age x in year t  ( ex,t ) in a period life table. It quantifies 
the remaining average number of years until the event takes 
place for an individual of exact age x , given hospitaliza-
tion patterns of year t  . In our case, ex,thosp quantified the 
expected average number of years until the first hospital 
admission for a person aged x in year t  . Adding 60 to the 
value of ex,thosp allowed the interpretation to be average age 
at first hospital admission.
Increases in the average age at first hospital admission are 
achieved when admissions at any age are reduced. Variation 
in age at first hospital admission can only be reduced when 
admissions at younger ages are reduced faster than admis-
sions at older ages. Separating younger and older ages is a 
unique threshold age, which is specific to each distribution 
and varies over time, but is typically below the average age 
of admission [29–31]. We calculated the threshold age, by 
formally identifying the age which a reduction in the age-
specific morbidity rate has no impact on variation [32] and 
report the percentage of admissions below and above the 
threshold age.
We quantified the amount of variation in age at first hos-
pital admission using the coefficient of variation (CoefV) 
and reported values as a percentage. The CoefV is a stand-
ard measure of dispersion and is defined as the ratio of the 
standard deviation to the average. Here, the CoefV reflects 
the variability in age at first hospital admission relative to 
the average age at first hospital admission. We calculated 
95% Confidence Intervals (95% CI) for ex,thosp and CoefV 
[33].
Results
Trends in average age at first admission
Figure 2 shows trends in the average age at first hospital 
admission for men and women.
The trend declined throughout the 1990s before rebound-
ing in the 2000s, resulting in a subtle u-shaped pattern. 
In 1987, the average age at first admission for men was 
67.8 years (95% CI 67.7–67.9). At the midpoint, 2001, the 
average age had increased only slightly to 67.9 years (95% 
CI 67.8–67.9). By 2014, the average age at first admission 
had increased to 69.5 years (95% CI 69.4–69.6). For women, 
the average age decreased slightly between 1987 and 2001: 
from 69.1 years (95% CI 69.1–69.2) to 68.5 years (95% 
CI 68.4–68.6). By 2014, the average age for women had 
increased to 70.5 years (95% CI 70.4–70.6).
Changes to the age distribution and premature 
admissions
Figure 3 shows the age distribution of first hospital admis-
sions for men and women in 1987, 2001, and 2014. For each 
Fig. 1  Cohort study population 
inclusion and exclusion criteria, 
using 1987 as an example
Total Danish Populaon
in 1987
N = 5,121,624
Populaon Aged 60+ 
in 1987
N = 1,058,204
Populaon at Risk
in 1987
N = 699,049
First Admission to Hospital
in 1987
N = 99,298
Admission in 7-Year Washout Period
between 1980 and 1986
N = 359,155
Populaon Under Age 60 
in 1987
N = 4,063,420
No Admission to Hospital
in 1987
N = 599,751
Excluded
Exlcuded
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of the three years, the threshold age is plotted as a vertical, 
dashed line.
The threshold age and the proportion of individuals expe-
riencing an admission below the threshold age increased 
over time among men and women. In 1987, the threshold 
age was 62.0 years for men and 17.3% experienced their 
first admission to hospital below the threshold age. The 
remaining 82.7% experienced a first admission to hospi-
tal above the threshold age. By 2001, the threshold age for 
men had increased to 62.4 years and the proportion which 
experienced a first admission to hospital below the thresh-
old age increased to 19.3%. In 2014, the threshold age for 
men increased further to 63.3 years and 21.3% experienced 
a first admission to hospital below the threshold age. For 
women, the threshold age in 1987 was 62.6 years and 19.5% 
of women experienced a first admission to hospital below 
the threshold age. The remaining 80.5% of women experi-
enced a first admission to hospital above the threshold age. 
Fig. 2  Average age at first 
hospital admission for men and 
women between 1987 and 2014
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By 2001, the threshold age for women and the percentage of 
women being admitted to hospital below the threshold age 
remained unchanged. The threshold age reached 64.0 years 
in 2014 and the percentage of women who experienced 
a first admission to hospital below the threshold age was 
22.9%. The remaining 77.1% experienced a first admission 
to hospital above the threshold age.
Trends in the coefficient of variation
We estimated the CoefV to quantify variation in the average 
age at first hospital admission. Figure 4 shows trends in the 
CoefV.
Among men, the CoefV in average age at first admis-
sion to hospital decreased from 9.1% (95% CI 9.0–9.1) in 
1987 to 8.7% (95% CI 8.6–8.7) in 2001. For women, the 
corresponding change was from 10.3% (95% CI 10.2–10.4) 
to 9.4% (95% CI 9.4–9.5). In the early 2000s, the trends in 
variation changed to slightly increasing. In 2014, the CoefV 
was 9.9% (95% CI 9.8–10.0) for men and 10.6% (95% CI 
10.5–10.6) for women.
Sensitivity
Our main results reflect hospital stays lasting a minimum of 
2 days, including all fatal events. We tested the sensitivity 
of our results by systematically altering three features of 
the analysis: (I) varying the minimum length of stay, (II) 
excluding fatal cases that occurred during admission, and 
(III) changing the washout period length. The substantive 
conclusions were generally consistent across the different 
sensitivity tests. However, the choice of cut-off for length 
of stay did have an impact. Stays lasting 1 day showed a 
slightly decreasing trend as opposed to the increasing trend 
found for all other lengths of stay that were analyzed. Results 
of sensitivity analyses are provided in Appendices 2 and 3 
(Supplementary Material).
Discussion
Summary of findings
We found the average age at first hospital admission at ages 
60, for admissions lasting more than 2 days, to be higher in 
2014 than in 1987, suggesting that people on average tend 
to live for longer without being admitted to hospital. At the 
same time, there may have been an increase in the proportion 
of first events occurring below the threshold age, and vari-
ation in age at first hospital admission may have increased. 
These findings indicate that individuals may face greater 
uncertainty in the timing of morbidity onset and that health 
at older ages may have become increasingly heterogeneous.
Interpretations and implications
A shift of hospital admissions towards older ages would sug-
gest that people are ageing with better health today than in 
the past. Healthy ageing is due to multiple factors, includ-
ing improved health during childhood, reduced exposure to 
hazardous working conditions, and changes in health behav-
iors such as smoking or diet [34, 35]. Another contribut-
ing factor is technological advancement which has enabled 
more individuals to survive longer in better health. Although 
Fig. 4  Variation in average age 
at first hospital admission for 
men and women between 1987 
and 2014
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some chronic diseases may show increased prevalence over 
time, they may now lead to a hospital admission later in 
life. Perhaps the strongest example of this is the treatment 
of cardiovascular diseases [36, 37]. Treatment has changed 
dramatically over time and mortality has declined, leading to 
more people surviving without serious cardiovascular events 
and only being admitted to hospital later in life.
At the same time, increasing variation in age at morbidity 
onset would indicate increasing diversity in healthy aging. 
The same technological advancements that have postponed 
adverse health events, have also enabled individuals to live 
for longer while managing chronic conditions, resulting in 
populations with more heterogeneous health profiles [9, 38, 
39]. Additionally, some component of increasing health vari-
ation could come from changes to the epidemiologic envi-
ronment experienced by older adults as infants and children. 
As control over infectious diseases has improved, weaker 
individuals, who would have died as children in previous 
decades, have survived to older ages, making for a more 
heterogeneous population [39].
Changes to population health are not the only factor 
which could have contributed to the changes in hospital 
admissions. Differences over time in admission and treat-
ment strategies will have had an impact [24]. In an attempt 
to identify changes in admission and treatment strategies, we 
examined 19 causes of admission using harmonized ICD-8 
and ICD-10 codes [Appendix 4 (Supplementary material)]. 
While the relative contribution from some causes decreased 
over the study period, other causes increased or remained 
stable. From these data, we were unable to identify any clear 
changes in admission or treatment strategies. Systematic 
changes are only likely to be identifiable when looking at 
diagnostic coding in even finer detail than was available. 
However, increasing the level of diagnostic detail would 
risk increasing potential misclassification bias [40]. An 
alternative approach would have been to compare detailed 
information on inpatient, outpatient, and primary healthcare 
attendances by cause of admission and length of treatment. 
Unfortunately, in Denmark, outpatient data and primary 
healthcare data do not contain suitable information for car-
rying out such analyses.
Conceptual and methodological considerations
Studies of morbidity traditionally use self-reports of func-
tional limitation, disability, or poor health from survey data 
to capture the concept of morbidity [4, 6, 41–44]. Empirical 
measures have diversified to encompass a range of dimen-
sions including; level of functioning (impairment, func-
tional limitation or activity restriction), severity of disability 
(severe or mild) and type of impairment (physical or cogni-
tive) [44]. Self-reported measures of health and disability 
give individuals the opportunity to share more information 
about their own health than objective measures capture. At 
the same time, self-reported measures of health and dis-
ability may be vulnerable to recall bias and systematic dif-
ferences in reporting behaviors [45–47]. While there is no 
consensus surrounding the most appropriate indicator of 
morbidity, a common feature is the intention to capture the 
impact disease has on daily life. However, recommendations 
have been made to (i) develop the concept of morbidity to 
better account for chronic conditions that do not result in 
functional limitation or disability and (ii) identify alterna-
tive data for capturing morbidity onset [6]. We have further 
highlighted that variation in age at onset, a key concept for 
monitoring mortality compression [15, 16, 48], has largely 
been overlooked in the morbidity compression debate.
Unfortunately, there are few longitudinal data sources 
covering an entire population that enable the identification 
of morbidity onset required to estimate variation. Even for 
a country with an established register based system, such as 
Denmark, options were limited. We identified first admission 
to hospital after age 60 as one illustrative example. From 
hospital admissions data we were able to estimate the inci-
dence rate of a medical diagnosis as a proxy indicator of 
morbidity [18, 19]. However, the administrative data used 
in this study were not free from limitations.
In Denmark, General Practitioners are gate keepers for 
determining access to hospital care [25, 49] and hospitals 
are not the only setting where a medical diagnosis can occur. 
Many chronic conditions, which develop slowly, may be 
diagnosed in primary healthcare or outpatient settings and 
our study will have underestimated the full burden of mor-
bidity. A restriction of our methodological approach, is that 
it is not directly applicable to international sources of admin-
istrative healthcare data that only capture individuals from 
the point of engagement [50]. A final limitation of this study 
is that changing the length of stay impacted the conclusions 
of the paper [Appendix 2 (Supplementary Material)]. Our 
main results defined an admission as an inpatient stay last-
ing for a minimum of 2 days. We found a stepwise increase 
in the average age and variation in age at first admission 
with every increase in minimum length of stay. Hospital 
stays lasting 1 day were an exception and showed a slightly 
decreasing trend. Therefore, measuring variation in age 
at morbidity onset from alternative administrative data is 
necessary. Medical diagnosis estimates from prescriptions 
data or primary healthcare data may yield very different 
results. The secular trends for increasing diagnostic activ-
ity and lower thresholds for hypertension and cholesterol 
may have decreased the age of morbidity onset and variation 
in age at onset in relation to primary healthcare diagnosis. 
At the same time, it is likely that these prevention effects 
may have contributed to the increase in age at morbidity 
onset and variation we identified using hospitalization data. 
Where possible, we encourage variation in age at morbidity 
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onset to be routinely measured alongside average indica-
tors of morbidity onset. Considering that variation in age at 
death has increased at older ages, increasing population level 
heterogeneity in age at morbidity onset is not an unlikely 
scenario [15, 39].
Concluding theoretical reflections
Morbidity compression studies have consistently calculated 
the average number of years spent in an unhealthy state, 
compared with life expectancy [5, 51–55]. However, Fries 
argued that the ‘analysis of variation, not of average values, 
becomes crucial’ [8] for understanding disease postpone-
ment. Although it has been forty years since Fries made 
this observation, empirical measurement of variation in 
morbidity onset has been overlooked. Incorporating varia-
tion in age at morbidity onset is important for individual life 
planning and population-level welfare: Pensions, social care 
and health services will have to adapt to the heterogeneous 
needs of ageing populations, something that average morbid-
ity measures cannot identify.
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